Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population
Mayo Clinic
Mayo Clinic
Centre Oscar Lambret
The Netherlands Cancer Institute
Zhejiang University
Emory University
Emory University
C17 Council
Roswell Park Cancer Institute
Medical University of Vienna
University of Colorado, Denver
Emory University
HonorHealth Research Institute
Sun Yat-sen University
Fudan University
Fudan University
Université de Sherbrooke
Baylor College of Medicine
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Air Force Military Medical University, China
Sun Yat-sen University
New Approaches to Neuroblastoma Therapy Consortium
AbbVie
University of Utah
Washington University School of Medicine
Taipei Medical University Shuang Ho Hospital
Wright State University
Case Comprehensive Cancer Center
Yonsei University
University of Cologne
OHSU Knight Cancer Institute
Centre Hospitalier Universitaire Vaudois
Sun Yat-sen University
Roswell Park Cancer Institute
University of Nebraska
Roswell Park Cancer Institute
Corewell Health West
Roswell Park Cancer Institute
City of Hope Medical Center
Medical Research Council
Assistance Publique Hopitaux De Marseille
M.D. Anderson Cancer Center
AstraZeneca
Tata Memorial Hospital
Tanta University
Alliance for Clinical Trials in Oncology
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Brigham and Women's Hospital
M.D. Anderson Cancer Center